BGB-3111-309
Recruiting
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
BeOne Study ID 
BGB-3111-309
ClinicalTrials.gov ID
EudraCT Number
2022-501147-32-00
China Drug Trials ID
CTR20230546
Study Overview
Sex:
All
Age: 18 Years / 75 Years
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / 75 Years
No Study Documents